238 related articles for article (PubMed ID: 8970997)
1. Role of Vif in human immunodeficiency virus type 1 reverse transcription.
Goncalves J; Korin Y; Zack J; Gabuzda D
J Virol; 1996 Dec; 70(12):8701-9. PubMed ID: 8970997
[TBL] [Abstract][Full Text] [Related]
2. Partial rescue of the Vif-negative phenotype of mutant human immunodeficiency virus type 1 strains from nonpermissive cells by intravirion reverse transcription.
Dornadula G; Yang S; Pomerantz RJ; Zhang H
J Virol; 2000 Mar; 74(6):2594-602. PubMed ID: 10684273
[TBL] [Abstract][Full Text] [Related]
3. Role of Vif in stability of the human immunodeficiency virus type 1 core.
Ohagen A; Gabuzda D
J Virol; 2000 Dec; 74(23):11055-66. PubMed ID: 11070000
[TBL] [Abstract][Full Text] [Related]
4. Vif is a RNA chaperone that could temporally regulate RNA dimerization and the early steps of HIV-1 reverse transcription.
Henriet S; Sinck L; Bec G; Gorelick RJ; Marquet R; Paillart JC
Nucleic Acids Res; 2007; 35(15):5141-53. PubMed ID: 17660191
[TBL] [Abstract][Full Text] [Related]
5. The Vif protein of human and simian immunodeficiency viruses is packaged into virions and associates with viral core structures.
Liu H; Wu X; Newman M; Shaw GM; Hahn BH; Kappes JC
J Virol; 1995 Dec; 69(12):7630-8. PubMed ID: 7494271
[TBL] [Abstract][Full Text] [Related]
6. Association of human immunodeficiency virus type 1 Vif with RNA and its role in reverse transcription.
Dettenhofer M; Cen S; Carlson BA; Kleiman L; Yu XF
J Virol; 2000 Oct; 74(19):8938-45. PubMed ID: 10982337
[TBL] [Abstract][Full Text] [Related]
7. Human immunodeficiency virus type 1 Vif protein is an integral component of an mRNP complex of viral RNA and could be involved in the viral RNA folding and packaging process.
Zhang H; Pomerantz RJ; Dornadula G; Sun Y
J Virol; 2000 Sep; 74(18):8252-61. PubMed ID: 10954522
[TBL] [Abstract][Full Text] [Related]
8. Vif is largely absent from human immunodeficiency virus type 1 mature virions and associates mainly with viral particles containing unprocessed gag.
Sova P; Volsky DJ; Wang L; Chao W
J Virol; 2001 Jun; 75(12):5504-17. PubMed ID: 11356958
[TBL] [Abstract][Full Text] [Related]
9. Ring finger protein ZIN interacts with human immunodeficiency virus type 1 Vif.
Feng F; Davis A; Lake JA; Carr J; Xia W; Burrell C; Li P
J Virol; 2004 Oct; 78(19):10574-81. PubMed ID: 15367624
[TBL] [Abstract][Full Text] [Related]
10. The replicative impairment of Vif- mutants of human immunodeficiency virus type 1 correlates with an overall defect in viral DNA synthesis.
Nascimbeni M; Bouyac M; Rey F; Spire B; Clavel F
J Gen Virol; 1998 Aug; 79 ( Pt 8)():1945-50. PubMed ID: 9714242
[TBL] [Abstract][Full Text] [Related]
11. Comprehensive investigation of the molecular defect in vif-deficient human immunodeficiency virus type 1 virions.
Gaddis NC; Chertova E; Sheehy AM; Henderson LE; Malim MH
J Virol; 2003 May; 77(10):5810-20. PubMed ID: 12719574
[TBL] [Abstract][Full Text] [Related]
12. Functional domains of APOBEC3G required for antiviral activity.
Li J; Potash MJ; Volsky DJ
J Cell Biochem; 2004 Jun; 92(3):560-72. PubMed ID: 15156567
[TBL] [Abstract][Full Text] [Related]
13. Human immunodeficiency virus type 1 Vif- mutant particles from restrictive cells: role of Vif in correct particle assembly and infectivity.
Borman AM; Quillent C; Charneau P; Dauguet C; Clavel F
J Virol; 1995 Apr; 69(4):2058-67. PubMed ID: 7884851
[TBL] [Abstract][Full Text] [Related]
14. Prolonged infection of peripheral blood lymphocytes by Vif-negative HIV type 1 induces resistance to productive HIV type 1 infection through soluble factors.
Simm M; Pekarskaya O; Potash MJ; Volsky DJ
AIDS Res Hum Retroviruses; 2000 Jul; 16(10):943-52. PubMed ID: 10890355
[TBL] [Abstract][Full Text] [Related]
15. Cytoskeleton association and virion incorporation of the human immunodeficiency virus type 1 Vif protein.
Karczewski MK; Strebel K
J Virol; 1996 Jan; 70(1):494-507. PubMed ID: 8523563
[TBL] [Abstract][Full Text] [Related]
16. Influence of primate lentiviral Vif and proteasome inhibitors on human immunodeficiency virus type 1 virion packaging of APOBEC3G.
Liu B; Yu X; Luo K; Yu Y; Yu XF
J Virol; 2004 Feb; 78(4):2072-81. PubMed ID: 14747572
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of tRNA₃(Lys)-primed reverse transcription by human APOBEC3G during human immunodeficiency virus type 1 replication.
Guo F; Cen S; Niu M; Saadatmand J; Kleiman L
J Virol; 2006 Dec; 80(23):11710-22. PubMed ID: 16971427
[TBL] [Abstract][Full Text] [Related]
18. Analysis of vif-defective human immunodeficiency virus type 1 (HIV-1) virions synthesized in 'non-permissive' T lymphoid cells stably infected with selectable HIV-1.
Ochsenbauer C; Wilk T; Bosch V
J Gen Virol; 1997 Mar; 78 ( Pt 3)():627-35. PubMed ID: 9049414
[TBL] [Abstract][Full Text] [Related]
19. Human immunodeficiency virus type 1 Vif does not influence expression or virion incorporation of gag-, pol-, and env-encoded proteins.
Fouchier RA; Simon JH; Jaffe AB; Malim MH
J Virol; 1996 Dec; 70(12):8263-9. PubMed ID: 8970945
[TBL] [Abstract][Full Text] [Related]
20. gag, vif, and nef genes contribute to the homologous viral interference induced by a nonproducer human immunodeficiency virus type 1 (HIV-1) variant: identification of novel HIV-1-inhibiting viral protein mutants.
D'Aloja P; Olivetta E; Bona R; Nappi F; Pedacchia D; Pugliese K; Ferrari G; Verani P; Federico M
J Virol; 1998 May; 72(5):4308-19. PubMed ID: 9557721
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
